U.S., July 18 -- ClinicalTrials.gov registry received information related to the study (NCT07712692) titled 'Evaluation of NWRD09 for HPV-16 Related Cervical HSIL' on July 08.
Brief Summary: This is a randomized, double-blind, placebo controlled Phase 2 study to determine the efficacy and safety of NWRD09 administered by intramuscular (IM) injection in adult women with histologically confirmed cervical high grade squamous intraepithelial lesion (HSIL) (cervical intraepithelial neoplasia grade 2 [CIN2] or grade 3 [CIN3]) associated with human papillomavirus (HPV) 16.
Study Start Date: Aug. 01
Study Type: INTERVENTIONAL
Condition:
High-grade Squamous Intraepithelial Lesion (HSIL)
Intervention:
BIOLOGICAL: NWRD09 Injection
NWRD09 admin...